7,381 followers
RT @FrontEndocrinol: New Research: The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of ra…
RT @FrontEndocrinol: New Research: The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of ra…
New Research: The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials: Background Diabetes mellitus (DM) is a global health problem, and it has become a shocking threat… https://t.co/C8sAss3t